If you are having trouble viewing this message, please view it in your web browser.

2022 Issue 1

PATENT Korean Patent Court Confirms for the First Time That a Pharmaceutical Compound Patent Covers Generic Prodrugs In a significant decision, the Patent Court recently confirmed that a generic product using a prodrug ester form of the active ingredient of AstraZeneca's blockbuster type II diabetes drug Forxiga® (dapagliflozin) was within the scope of a compound patent covering dapagliflozin. Read more The Supreme Court Clarifies the Limits of Application of Res Judicata in Patent Cases The Supreme Court clarifies res judicata, which prevents a re-trial of a final and conclusive IPTAB patent decision "based on the same facts and evidence," but does not apply to IPTAB decisions based on a "rejection" for non-substantive reasons. Read more Korea Announces Comprehensive "Technology Protection Strategy" for Core Technologies and Infrastructure The Korean government has revised its policy framework to respond to changes in the global technology protection environment. Read more

TRADEMARK, DESIGN, COPYRIGHT & UNFAIR COMPETITION New Amendments to the Korean Trademark Act in the New Year The National Assembly promulgated amendments to the Trademark Act, which supplement the definition of "use of a trademark" and enhance procedural convenience for applicants as well as their ability to secure rights. Read more Korean Customs Releases 2020 Statistics Showing Increased Seizures of Counterfeit Goods The numbers reveal some interesting trends that may reflect the large increase in online shopping due to the COVID-19 pandemic. Read more

EDITORS John J. KIM & Inchan Andrew KWON

NEWS Highest Tier in All Nine Areas and 37 Individual Recognitions – Chambers Global 2022 "Tier 1" in All 15 Practice Areas – The Legal 500 Asia Pacific 2022 Top Ranking in 18 Areas and 74 Individual Recognitions – Chambers Asia-Pacific 2022

INTELLECTUAL PROPERTY Jeongdong Building, 17F, 21-15 Jeongdong-gil, Jung-gu, Seoul 04518, Korea T +82 2 2122 3900  |  F +82 2 2122 3800/741 0328  |  www.ip.kimchang.com  |  ip-group@kimchang.com   This legal updates is provided for general informational purposes only and should not be considered a legal opinion of KIM & CHANG nor relied upon in lieu of specific advice. Recipients of this publication, whether clients or otherwise, should not act or refrain from acting on the basis of any information included in this publication without seeking appropriate legal or other professional advice. For more newsletters and legal updates of KIM & CHANG, please visit our website - www.kimchang.com or www.ip.kimchang.com [UNSUBSCRIBE] If you do not wish to receive our e-mail service, please click here. © 2022 Kim & Chang